https://www.techtarget.com/pharmalifesciences/news/366607147/GSK-Alector-to-Develop-Antibodies-for-Neurodegenerative-Diseases
GSK and Alector partner to develop antibodies, AL001 and AL101. The antibodies will elevate progranulin levels, a key regulator of immune activity in the brain...
neurodegenerative diseasesgskalectordevelopantibodies
https://finviz.com/news/167000/alector-to-host-virtual-research-and-development-event-highlighting-pgrn-franchise-and-brain-carrier-programs
Stock screener for investors and traders, financial visualizations.
alectorhostvirtualresearchdevelopment